Evidence map›Paper›PMID 20377113›Full record

ArticleAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology2010

The traditional Chinese herbal formula ASHMI inhibits allergic lung inflammation in antigen-sensitized and antigen-challenged aged mice.

Paula J Busse, Brian Schofield, Neil Birmingham, Nan Yang, Ming-Chuan Wen, Tengfei Zhang, Kamal Srivastava, Xiu-Min Li

Open access · greenAbstract read
In one paragraph

Article in Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. Low-Dose Oral Ginger Improves Daily Symptom Scores in Asthma.Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  4. Article
  5. Traditional Chinese Medicine (TCM) and Allergic Diseases.Current allergy and asthma reports · 2020
    Review
  6. Article
  7. Review
  8. Cellular senescence in the lung across the age spectrum.American journal of physiology. Lung cellular and molecular physiology · 2019
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Traditional Chinese medicine and immune regulation.Clinical reviews in allergy & immunology · 2013
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Paula J BusseDivision of Clinical Immunology, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA. paula.busse@mssm.edu
Brian Schofield
Neil Birmingham
Nan Yang
Ming-Chuan Wen
Tengfei Zhang
Kamal Srivastava
Xiu-Min Li
Icahn School of Medicine at Mount Sinai · USJohns Hopkins University · US

Funding

Therapy (CHT) for AsthmaP01AT002647 · NCCIH · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI LI, XIU-MIN · 2005 to 2009
$5.8M
Contribution of TNF-alpha to mucus cell production in asthmaK08AI063932 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BUSSE, PAULA J · 2006 to 2010
$599k
NCCIH NIH HHS P01 AT002647NIAID NIH HHS K08 AI063932
6 · The paper itself

Abstract

backgroundAlthough asthma is typically characterized as a childhood disease, it can develop later in life. Older asthmatic patients may be at increased risk for corticosteroid adverse effects. We developed a novel traditional Chinese medicine to treat asthma called antiasthma simplified herbal medicine intervention (ASHMI). Herbal products may offer safer adjunctive treatment for older asthmatic patients.

objectiveTo investigate the effects of ASHMI on characteristics of allergic asthma in an aged mouse model of asthma.

methodsBALB/c mice (6 weeks old [young] and 6, 12, and 18 months old [aged]) received ASHMI treatment before and during intraperitoneal ovalbumin sensitization and intratracheal challenges. The control groups were untreated, age-matched, ovalbumin-sensitized and ovalbumin-challenged mice (ovalbumin mice) and naive mice. After the final antigen challenge, airway pressure (defined as the time-integrated change in peak airway pressure) after acetylcholine provocation was measured, representing airway hyperresponsiveness, and bronchoalveolar lavage fluid, sera, lung tissues for histologic analysis, messenger RNA, and collagen were collected.

resultsMean time-integrated change in peak airway pressure values in 6-week-old and 6-, 12-, and 18-month-old ASHMI ovalbumin mice were significantly reduced compared with those of age-matched, nontreated ovalbumin mice. Bronchoalveolar lavage fluid eosinophil numbers were significantly lower in all ASHMI ovalbumin mice. Treatment with ASHMI of young and aged ovalbumin mice resulted in significantly decreased lung inflammation, detected via hematoxylin-eosin staining; airway mucous cell metaplasia, determined by means of periodic acid-Schiff staining; and messenger RNA copy numbers of the mucin gene MUC5AC. Levels of ovalbumin specific IgE and the T(H)2 cytokines interleukin 4 (IL-4), IL-5, and IL-13 in lung and splenocyte cultures were reduced. Interferon gamma secretion was increased. Treatment with ASHMI reduced collagen production.

conclusionTreatment with ASHMI reduces several features of asthma in aged antigen-sensitized and antigen-challenged mice.

Indexed as

AgingAnimalsAnti-Asthmatic AgentsAntigensAsthmaDrug Evaluation, PreclinicalDrugs, Chinese HerbalFemaleMiceMice, Inbred AKRMice, Inbred BALB COvalbuminTreatment OutcomeAnti-Asthmatic AgentsAntigensDrugs, Chinese HerbalOvalbumin

Identifiers

PMID20377113
PMCPMC4608683
OpenAlexW2006601417

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.